MedPath

HD-Charge: Indirect and Out-of-Pocket Costs of Huntington's Disease in the United States

Completed
Conditions
Huntington's Disease
Interventions
Behavioral: Online survey
Registration Number
NCT03628235
Lead Sponsor
CHDI Foundation, Inc.
Brief Summary

Huntington's disease (HD) is a rare, inherited and progressive neurodegenerative disorder for which hallmark symptoms include movement disorders, loss of cognitive faculties and psychiatric disturbances. With the progression of the disease, patients require increasing level of medical care, caregiver support, and long-term care, which lead to substantial burden of illness. Very little data are available on the direct or indirect costs for HD. The direct medical costs of HD in the US have been summarized from retrospective commercial and Medicaid claims data analysis. The indirect and out-of-pocket costs of HD in the US have not been quantified. This study will help to bridge these gaps.

This study is a single-assessment, cross-sectional online survey administered to Huntington disease gene expansion carriers (HDGECs) and companions of HDGECs by HD stage to understand the indirect and out-of-pocket costs of Huntington's disease in the US.

Detailed Description

The survey collects the following data from each HDGEC and companion:

1. Participant demographics (for HDGECs and companion)

2. Informal care received (for HDGECs only)

3. Out of pocket HD costs (for HDGECs and companion)

4. Current employment status (for HDGECs and companion)

5. Non-work and work care giving time that companion spends taking care of HDGEC (for companion only)

6. Work Productivity and Activity Impairment (WPAI) Questionnaire (for HDGECs and companion)

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
233
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Companions of early stage HDGECsOnline survey-
Companions of middle stage HDGECsOnline survey-
Early stage HDGECsOnline surveyCAG length ≥ 40; DCL = 4, TFC ≥ 11
Middle stage HDGECsOnline surveyCAG length ≥ 40; DCL = 4, 7 ≤ TFC ≤ 10
Companions of late stage HDGECsOnline survey-
Late stage HDGECsOnline surveyCAG length ≥ 40; DCL = 4, 0 ≤ TFC ≤ 6
Primary Outcome Measures
NameTimeMethod
Quantify the indirect costs associated with productivity loss for HDGECs and companions12 months

Productivity loss is measured by annual lost wages and it is collected in the survey's employment questionnaires and WPAI

Quantify out-of-pocket expenses for HDGECs and companions12 months

The indirect costs associated with the total annual out-of-pocket expenses.

Identify the indirect costs associated with informal care received for HDGECs12 months

The total informal care time received during a typical week

Quantify the indirect costs associated with non-work caregiving time for companions12 months

The indirect costs associated with the annual opportunity costs of companion

Secondary Outcome Measures
NameTimeMethod
The proportion of Dual Role Companions, differentiated by HD stage of the companion12 months
Identify the reasons for HDGEC and companion's unemployment or underemployment12 months
To understand traditional disease staging system based on total functional capacity (TFC)12 months

For HDGECs and Companions: Understand how the traditional disease staging system, based on the TFC score, relates to a staging system based on resource utilization questionnaire and comorbid conditions developed in Divino et al. (2013)

Trial Locations

Locations (11)

The Ohio State University

🇺🇸

Columbus, Ohio, United States

St. Joseph's Hospital and Medical Center

🇺🇸

Phoenix, Arizona, United States

Rocky Mountain Movement Disorder, P.C.

🇺🇸

Englewood, Colorado, United States

Washington University

🇺🇸

Saint Louis, Missouri, United States

Columbia University Medical Center

🇺🇸

New York, New York, United States

University of Texas Health Science Center at Houston

🇺🇸

Houston, Texas, United States

University of Washington

🇺🇸

Seattle, Washington, United States

Vanderbilt University Medical Center

🇺🇸

Nashville, Tennessee, United States

Hereditary Neurological Disease Centre, Inc.

🇺🇸

Wichita, Kansas, United States

University of South Florida

🇺🇸

Tampa, Florida, United States

University of Pittsburgh

🇺🇸

Pittsburgh, Pennsylvania, United States

© Copyright 2025. All Rights Reserved by MedPath